On May 17, 2022, the Board of Directors of Mereo BioPharma Group plc appointed Dr. Abdul Mullick to the Board, effective immediately. Following Dr. Mullick's appointment the Board will consist of ten members. Following the Company's Annual General Meeting, Dr. Peter Fellner stepped down as chair of the Board and is being replaced by Michael Wyzga, who will serve as chair of the Board going forward.

Dr. Mullick currently serves as President & Chief Executive Officer of Kyowa Kirin International plc. Michael Wyzga has served on Board since April 2019. Mr. Wyzga is currently the President of MSW Consulting Inc.